KaloBios Pharmaceuticals Inc (NASDAQ:KBIO)

0.49
Delayed Data
As of Jul 02
 -0.009 / -1.80%
Today’s Change
0.36
Today|||52-Week Range
2.35
-71.68%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for KaloBios Pharmaceuticals Inc have a median target of 8.00, with a high estimate of 8.00 and a low estimate of 8.00. The median estimate represents a +1,532.65% increase from the last price of 0.49.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in KaloBios Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.21
Sales
$0.00
Reporting Date
Aug 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 27.59%
 
 
 
 
 
 
Growthannually 29.57%
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account